SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-026548
Filing Date
2021-05-11
Accepted
2021-05-11 16:11:52
Documents
61
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q sndx-10q_20210331.htm   iXBRL 10-Q 2046864
2 EX-31.1 sndx-ex311_14.htm EX-31.1 10276
3 EX-31.2 sndx-ex312_9.htm EX-31.2 10724
4 EX-32.1 sndx-ex321_12.htm EX-32.1 11870
  Complete submission text file 0001564590-21-026548.txt   7778791

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA sndx-20210331.xsd EX-101.SCH 54002
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sndx-20210331_cal.xml EX-101.CAL 48356
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sndx-20210331_def.xml EX-101.DEF 176512
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE sndx-20210331_lab.xml EX-101.LAB 384558
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sndx-20210331_pre.xml EX-101.PRE 288078
10 EXTRACTED XBRL INSTANCE DOCUMENT sndx-10q_20210331_htm.xml XML 1580417
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37708 | Film No.: 21911423
SIC: 2834 Pharmaceutical Preparations